Douglas Melamed

Doug Melamed is Professor of the Practice of Law at Stanford Law School.  He joined the Stanford faculty in 2014.  In the Fall of 2017, he was the Florence Rogatz Visiting Professor in the Practice of Law at Yale Law School.

From 2009 until 2014, Doug was Senior Vice President and General Counsel of Intel Corporation and was responsible for overseeing Intel’s legal, government affairs, and corporate affairs departments. Prior to joining Intel in 2009, he was a partner in the Washington, D.C., office of WilmerHale, a global law firm in which he served as a chair of the Antitrust and Competition Practice Group.  From 1996 to 2001, he served in the U.S. Department of Justice as Acting Assistant Attorney General in charge of the Antitrust Division and, before that, as Principal Deputy Assistant Attorney General.

Doug has authored numerous articles on antitrust, patent law, and law and economics. He is a member of the American Law Institute and a Contributing Editor of the Antitrust Law Journal and a former member of the boards of directors of the Nasdaq exchanges.  Doug received his B.A. from Yale and his J.D. from Harvard, where he was an editor of the Harvard Law Review.

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More

Don’t Tax Invention: The Risks of a Patent Tax

By Sujai Shivakumar and Chris Borges The Commerce Department is reportedly considering a novel revenue-raising idea to address the national debt: a “patent tax.” Under this proposal, patent holders would be required to pay the federal government between 1 and 5 percent of their patents’ assessed value each year. While the
Read More